Business, energy, technology, markets and global industry news from Business News Today

Sanofi Ventures

PharmaDeviceNews Sanofi Ventures
AdvanCell’s US$315 million financing supports ADVC001 prostate cancer trials and expanded Lead-212 radiopharmaceutical manufacturing. Representative image.
Pharma & Biotech

Why investors just put $315m behind AdvanCell’s prostate cancer alpha therapy

AdvanCell’s US$315 million Series D backs ADVC001 trials and Lead-212 manufacturing, but Phase 2 evidence remains the decisive test.

Read More
A retinal specialist reviews advanced eye scans as Memento Medicines develops MMT-205 to challenge established treatments for wet age-related macular degeneration and diabetic macular edema. Representative image.
Pharma & Biotech

Memento Medicines launches with $93m, but can MMT-205 challenge retinal drug leaders?

Discover how Memento Medicines plans to challenge retinal drug leaders with $93 million, MMT-205 and a direct Tie2 activation strategy.

Read More